Janine Maenza

3.0k total citations
37 papers, 1.6k citations indexed

About

Janine Maenza is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Janine Maenza has authored 37 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Virology, 24 papers in Infectious Diseases and 10 papers in Immunology. Recurrent topics in Janine Maenza's work include HIV Research and Treatment (29 papers), HIV/AIDS Research and Interventions (21 papers) and HIV/AIDS drug development and treatment (16 papers). Janine Maenza is often cited by papers focused on HIV Research and Treatment (29 papers), HIV/AIDS Research and Interventions (21 papers) and HIV/AIDS drug development and treatment (16 papers). Janine Maenza collaborates with scholars based in United States, Canada and France. Janine Maenza's co-authors include Ann C. Collier, Claire E. Stevens, William G. Merz, Joel E. Gallant, Jeanne Keruly, Joanne D. Stekler, Lawrence Corey, J. Shawn Justement, Susan Moir and Claire W. Hallahan and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and PLoS ONE.

In The Last Decade

Janine Maenza

36 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janine Maenza United States 24 1.1k 1.0k 537 336 224 37 1.6k
Gregory M. Laird United States 16 1.1k 1.1× 1.4k 1.4× 418 0.8× 623 1.9× 323 1.4× 29 1.8k
Charlotte Charpentier France 24 1.4k 1.3× 1.2k 1.2× 439 0.8× 117 0.3× 250 1.1× 117 1.9k
Sean Philpott United States 18 667 0.6× 739 0.7× 208 0.4× 350 1.0× 181 0.8× 39 1.3k
Susan Allen United States 11 1.1k 1.1× 1.8k 1.7× 460 0.9× 745 2.2× 361 1.6× 16 2.0k
Tidiane Siby Senegal 13 1.0k 1.0× 1.1k 1.1× 359 0.7× 224 0.7× 86 0.4× 17 1.5k
Photini Kiepiela South Africa 25 911 0.9× 1.2k 1.1× 636 1.2× 852 2.5× 314 1.4× 56 2.1k
Jenna Rychert United States 19 433 0.4× 389 0.4× 484 0.9× 359 1.1× 230 1.0× 31 1.4k
Remko van Leeuwen Netherlands 23 1.8k 1.7× 1.5k 1.4× 651 1.2× 208 0.6× 166 0.7× 40 2.4k
Omu Anzala Kenya 18 653 0.6× 653 0.6× 407 0.8× 286 0.9× 87 0.4× 54 1.1k
Robert Paris United States 19 432 0.4× 564 0.5× 334 0.6× 435 1.3× 228 1.0× 61 1.3k

Countries citing papers authored by Janine Maenza

Since Specialization
Citations

This map shows the geographic impact of Janine Maenza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janine Maenza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janine Maenza more than expected).

Fields of papers citing papers by Janine Maenza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janine Maenza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janine Maenza. The network helps show where Janine Maenza may publish in the future.

Co-authorship network of co-authors of Janine Maenza

This figure shows the co-authorship network connecting the top 25 collaborators of Janine Maenza. A scholar is included among the top collaborators of Janine Maenza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janine Maenza. Janine Maenza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gervassi, Ana, Lennie Chen, Sheila Styrchak, et al.. (2024). Antigen specificities and proviral integration sites differ in HIV-infected cells by timing of antiretroviral treatment initiation. Journal of Clinical Investigation. 134(14). 1 indexed citations
2.
Curlin, Marcel E., Jason Shao, Gabriela Diaz, et al.. (2020). Long-term mucosal T cell activation and homing phenotypes in recipients of an Ad5-vectored HIV vaccine. Vaccine. 38(36). 5814–5821. 2 indexed citations
3.
Kublin, James G., Sean C. Murphy, Janine Maenza, et al.. (2020). Safety, Pharmacokinetics, and Causal Prophylactic Efficacy of KAF156 in a Plasmodium falciparum Human Infection Study. Clinical Infectious Diseases. 73(7). e2407–e2414. 16 indexed citations
4.
Stekler, Joanne D., Kenneth Tapia, Janine Maenza, et al.. (2018). No Time to Delay! Fiebig Stages and Referral in Acute HIV infection: Seattle Primary Infection Program Experience. AIDS Research and Human Retroviruses. 34(8). 657–666. 11 indexed citations
5.
Stekler, Joanne D., Ingrid A. Beck, Joshua T. Herbeck, et al.. (2018). Transmission of HIV-1 drug resistance mutations within partner-pairs: A cross-sectional study of a primary HIV infection cohort. PLoS Medicine. 15(3). e1002537–e1002537. 11 indexed citations
6.
Larsen, Brendan B., Brandon S. Maust, Lennie Chen, et al.. (2015). Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection. Journal of Virology. 89(20). 10303–10318. 23 indexed citations
7.
Stekler, Joanne D., Kenneth Tapia, Sarah Holte, et al.. (2014). Lack of Resistance to Integrase Inhibitors among Antiretroviral-Naive Subjects with Primary HIV-1 Infection, 2007–2013. Antiviral Therapy. 20(1). 77–80. 50 indexed citations
8.
Hawkins, Natalie, Warren L. Dinges, Yi Liu, et al.. (2013). Superior Control of HIV-1 Replication by CD8+ T Cells Targeting Conserved Epitopes: Implications for HIV Vaccine Design. PLoS ONE. 8(5). e64405–e64405. 40 indexed citations
9.
McElrath, M. Juliana, Kimberly S. Smythe, Julie Randolph‐Habecker, et al.. (2013). Comprehensive Assessment of HIV Target Cells in the Distal Human Gut Suggests Increasing HIV Susceptibility Toward the Anus. JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(3). 263–271. 46 indexed citations
10.
Stekler, Joanne D., Robert Wellman, Sarah Holte, et al.. (2012). Are there benefits to starting antiretroviral therapy during primary HIV infection? Conclusions from the Seattle Primary Infection Cohort vary by control group. International Journal of STD & AIDS. 23(3). 201–206. 12 indexed citations
11.
Stekler, Joanne D., Sarah Holte, Janine Maenza, et al.. (2011). Prevalence and Impact of Minority Variant Drug Resistance Mutations in Primary HIV-1 Infection. PLoS ONE. 6(12). e28952–e28952. 30 indexed citations
12.
Rosenberg, Eric, Barney S. Graham, Ellen S. Chan, et al.. (2010). Safety and Immunogenicity of Therapeutic DNA Vaccination in Individuals Treated with Antiretroviral Therapy during Acute/Early HIV-1 Infection. PLoS ONE. 5(5). e10555–e10555. 45 indexed citations
13.
Stekler, Joanne D., Sarah Holte, Janine Maenza, et al.. (2008). HIV Dynamics in Seminal Plasma during Primary HIV Infection. AIDS Research and Human Retroviruses. 24(10). 1269–1274. 34 indexed citations
14.
Curlin, Marcel E., Kurt Diem, Hong Zhao, et al.. (2008). Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B viruses. Virology. 374(2). 229–233. 58 indexed citations
15.
Stekler, Joanne D., Janine Maenza, Claire E. Stevens, et al.. (2007). Screening for Acute HIV Infection: Lessons Learned. Clinical Infectious Diseases. 44(3). 459–461. 35 indexed citations
16.
Stekler, Joanne D., Janine Maenza, Claire E. Stevens, et al.. (2006). Abacavir hypersensitivity reaction in primary HIV infection. AIDS. 20(9). 1269–1274. 31 indexed citations
17.
Vanhems, Philippe, Jean‐Pierre Routy, Bernard Hirschel, et al.. (2002). Clinical Features of Acute Retroviral Syndrome Differ by Route of Infection but Not by Gender and Age. JAIDS Journal of Acquired Immune Deficiency Syndromes. 31(3). 318–321. 10 indexed citations
18.
Kuritzkes, Daniel R., Ian C. Marschner, Victoria A. Johnson, et al.. (1999). Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. AIDS. 13(6). 685–694. 38 indexed citations
19.
Maenza, Janine, William G. Merz, Mark Romagnoli, et al.. (1997). Infection Due to Fluconazole-Resistant Candida in Patients with AIDS: Prevalence and Microbiology. Clinical Infectious Diseases. 24(1). 28–34. 112 indexed citations
20.
Maenza, Janine, Jeanne Keruly, Richard Moore, et al.. (1996). Risk Factors for Fluconazole-Resistant Candidiasis in Human Immunodeficiency Virus-Infected Patients. The Journal of Infectious Diseases. 173(1). 219–225. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gregory M. Laird Breakdown of academic impact, for papers by Charlotte Charpentier Breakdown of academic impact, for papers by Sean Philpott Breakdown of academic impact, for papers by Susan Allen Breakdown of academic impact, for papers by Tidiane Siby Breakdown of academic impact, for papers by Photini Kiepiela Breakdown of academic impact, for papers by Jenna Rychert Breakdown of academic impact, for papers by Remko van Leeuwen Breakdown of academic impact, for papers by Omu Anzala Breakdown of academic impact, for papers by Robert Paris
Rankless by CCL
2026